(PharmaNewsWire.Com, February 02, 2017 ) Global DNA polymerase market has grown abundantly over the last few decades owing to the increasing demand for DNA polymerase in various industries such as biopharmaceuticals, diagnostic centers, research centers and many other.
DNA is unique to everyone, it is more unique than a fingerprint. Hence DNA polymerase has also entered in the forensic industry as this uniqueness can be used to great advantages in this field. The DNA is analyzed from the drop of blood at crime scene and is compared with the DNA of suspects. This is possible by using polymerase chain reaction in which a small sample of DNA is multiplied and large samples are created.
The various advantages offered by DAN polymerase are anticipated to boost the demand for global DNA polymerase market during the forecast period 2015-2025. DNA polymerase is very important as it duplicates our genetic information. It is the most accurate enzyme, it creates an exact copy of the DNA every time making less than one mistake in billion times.
Various reagents that have been widely used in DNA polymerase are antibodies, primers and buffers. And these various reagent segments are forecasted to grow with an effective CAGR during the forecast period.
Substantial increase in demand for DNA polymerase market has been reported across the globe due to the prevalence of diseases like cancer, neurodegenerative diseases and genetic disorders. As per the data suggested by WHO, cancer is among the leading causes of death all over the world and the number of cases of cancer is expected to increase by 70% over the next two decades. The increasing consumption of DNA polymerase by biopharmaceutical industry is another major driving force behind the growth of global DNA polymerase market as biopharmaceutical industry is experiencing a boom over the last few years.
In addition, the Increasing usage of DNA polymerase in forensic industry is poised to propel the demand for global DNA polymerase market during the forecast period 2015-2025, owing to the rising growth rate of crimes across the world.
DNA PolymeraseMarket: Market Segmentation
The DNA polymerase market is broadly classified into four segments on the basis of therapeutic applications
Cancer Neurodegenerative diseases Genetic Disorders Others The DNA polymerase market is broadly classified into four segments on the basis of reagents
Antibodies Primers Buffer Others The DNA polymerase market is broadly classified into four segments on the basis of End use
Biopharmaceutical Industry Diagnostic Centers Forensic Industry Research centers DNA PolymeraseMarket: Regional Outlook
Depending on geographic regions, global DNA polymerase market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. As of 2014 North America dominated the global DNA Polymerase market in terms of market revenue followed by Western Europe. The growing biopharmaceutical industry in countries like US are pulling the demand for DNA polymerase market in North America.
Moreover, Asia Pacific is anticipated to show the effective growth in DNA polymerase market during the forecast period 2015-2025 due the growing forensic industry and diagnostic centers in this region.
DNA PolymeraseMarket: Market Players
The global DNA polymerase market developing with significant growth rate. Some of the major players operating in global DNA polymerase market are Novus, Excell Bio, Biomiga, Stratagene, SYGNIS, Roche, Finnzymes, Cyagen, Tiangen, Genetimes and others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
